CSIMarket


Radnet Inc   (RDNT)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Radnet Inc

RDNT's Fundamental analysis








Looking into Radnet Inc growth rates, revenue grew by 14.83 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 971

Medical Laboratories industry recorded deterioration of revenues by

Radnet Inc 's net income grew by 273.29 % in III. Quarter 2023 year on year, above company average,

More on RDNT's Growth


Radnet Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 13.74 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.11.


More on RDNT's Valuation
 
 Total Debt (Millions $) 860
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 181,623
 Net Income/Employee (TTM) $ 3,369
 Receivable Turnover (TTM) 9.23
 Tangible Book Value (Per Share $) 0.41

Radnet Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 13.74 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.11.

Radnet Inc Price to Book Ratio is at 4.19 lower than Indusry Avg. of 422.39. and higher than S&P 500 Avg. of 0.01

More on RDNT's Valuation

  Market Capitalization (Millions $) 3,337
  Shares Outstanding (Millions) 69
  Employees 8,700
  Revenues (TTM) (Millions $) 1,580
  Net Income (TTM) (Millions $) 29
  Cash Flow (TTM) (Millions $) 243
  Capital Exp. (TTM) (Millions $) -272
  Total Debt (Millions $) 860
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 181,623
  Net Income/Employee(TTM) $ 3,369
  Receivable Turnover Ratio (TTM) 9.23
  Tangible Book Value (Per Share $) 0.41

  Market Capitalization (Millions $) 3,337
  Shares Outstanding (Millions) 69
  Employees 8,700
  Revenues (TTM) (Millions $) 1,580
  Net Income (TTM) (Millions $) 29
  Cash Flow (TTM) (Millions $) 243
  Capital Exp. (TTM) (Millions $) -272


    RDNT's Profitability Comparisons
Radnet Inc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2023 to 10.76 % from 6.05 % in II. Quarter.

Radnet Inc net profit margin of 5.99 % is currently ranking no. 9 in Medical Laboratories industry, ranking no. 132 in Healthcare sector and number 1763 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 1.56
  Total Debt to Equity (MRQ) 1.08
  Tangible Leverage Ratio (MRQ) 74.03
  Asset Turnover Ratio (TTM) 0.64
  Inventory Turnover Ratio (TTM) -



Radnet Inc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2023 to 10.76 % from 6.05 % in II. Quarter.

Radnet Inc net profit margin of 5.99 % is currently ranking no. 9 in Medical Laboratories industry, ranking no. 132 in Healthcare sector and number 1763 in S&P 500.

More on RDNT's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com